Abstract:The desire for a cancer theranostic system with simultaneously accurate diagnosis and efficient therapy is undeniably interminable. Heretofore, theranostic systems with simple components were designed for cancer theranostics but with confined accuracy of diagnosis and side effects of administered drugs. Here, we report an activatable theranostic system for simultaneously imaging dual cancer-related RNAs, mRNA Bcl-2 and piRNA-36026, and combined gene-chemotherapy through the target-induced intracellular disassembly of DNA tetrahedron. Briefly, five customized oligonucleotides are used to assemble the functionalized DNA tetrahedron. The relevant functional nucleic acids, including the antisequence of mRNA Bcl-2, the antisequence of piRNA-36026, and aptamer AS1411, are designed in the customized oligonucleotides with the signal reporters Cy3 and Cy5. Doxorubicin (DOX) is loaded in the functionalized DNA tetrahedron by inlaying between cytosine and guanine to form the activatable cancer theranostic system. The activatable cancer theranostic system is able to recognize MCF-7 cells by aptamer AS1411 and then enter the cells. In the presence of targets, the antisequences in the activatable cancer theranostic system hybridize with intracellular mRNA Bcl-2 and piRNA-36026, leading to the fluorescence signal recovery of Cy3 and Cy5 and the downregulation of two targets in the cytoplasm as well as the consequent apoptosis of MCF-7 cells in the form of gene therapy. Interestingly, as the antisequences are designed in the assembly strands, the hybridization between targets and the antisequences results in the disassembly of the activatable cancer theranostic system and the release of DOX as well as sequential chemotherapy. Advantageously, the activatable cancer theranostic system can achieve imaging of dual cancer-related RNAs with an imaging time window as long as 15 h and exhibit an obvious therapeutic effect in vivo. Therefore, this work is in furtherance of exploration for activatable cancer theranostic systems with high accuracy and efficiency and sheds new light on the development of precision medicine.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.2c00364.Sequence data sets used in this work; other nanoprobes used in this work; experimental section; formation of the FDT; feasibility and the majorization of the signal-to-background ratio for the FDT; response ability of the FDT to synthetic DNA targets in buffer; validation of FDT disassembly; digestion resistance ability of the FDT; drug-loading efficiency of the FDT; confocal laser scanning microscopy analysis of DOX release in MCF-7 cells; killing effect of AT&TCTS in different cells; and reference (PDF)This article has not yet been cited by other publications.

Two-in-one Combination Therapy of Fluoronucleoside Analogues and Triplex Forming Oligonucleotides

Two-in-One Chemogene Assembled from Drug-Integrated Antisense Oligonucleotides to Reverse Chemoresistance.

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

A dual-functional nanomedicine combining fluorinated antisense oligonucleotide with chemotherapeutic drug for synergistic gene-chemo tumor treatment

Enzymatic Synthesis of Chemical Nuclease Triplex-Forming Oligonucleotides with Gene-Silencing Applications

Characterization and quantification of triple helix formation in chromosomal DNA

mRNA-responsive two-in-one nanodrug for enhanced anti-tumor chemo-gene therapy

Novel strategy for activating gene expression through triplex DNA formation targeting epigenetically suppressed genes

Integrating Theory with Experimental Studies on the Directed Assembly of Phenforminium 5-Fluorouracilate Toward Enhanced in Vitro/Vivo Properties and Synergistic Antitumor Efficacy

Activatable Dual Cancer-Related RNA Imaging and Combined Gene-Chemotherapy through the Target-Induced Intracellular Disassembly of Functionalized DNA Tetrahedron

Optical Antisense Tumor Targeting in Vivo with an Improved Fluorescent Dna Duplex Probe

Repair of triplex-directed DNA alkylation by nucleotide excision repair

Dual regulation of the orderly aggregation of covalent organic frameworks at the molecular level and nanoscale to achieve efficient phototherapy and gene therapy

Minimum number of 2'-O-(2-aminoethyl) residues required for gene knockout activity by triple helix forming oligonucleotides

Combinational Application of Metal–organic Frameworks‐based Nanozyme and Nucleic Acid Delivery in Cancer Therapy

C4'-Fluorinated Oligodeoxynucleotides: Synthesis, Stability, Structural Studies.

Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide

Fluorescence detection of single-nucleotide polymorphism with single-strand triplex-forming DNA probes.

Co-delivery Nanocarriers Targeting Folate Receptor and Encapsulating 2-Deoxyglucose and Α-Tocopheryl Succinate Enhance Anti-Tumor Effect in Vivo.